PIII

P3 Partners (PIII)

P3 Partners Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PIII

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/10	06 : 26	Business Wire	P3 Health Partners Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:PIII	P3 Partners Inc
2024/05/09	05 : 05	Business Wire	P3 Health Partners Names Dr. Aric Coffman as CEO	NASDAQ:PIII	P3 Partners Inc
2024/05/09	05 : 05	Business Wire	P3 Health Partners Announces First Quarter 2024 Results	NASDAQ:PIII	P3 Partners Inc
2024/05/02	21 : 00	Business Wire	P3 Health Partners Schedules First Quarter 2024 Earnings Release and Conference Call	NASDAQ:PIII	P3 Partners Inc
2024/04/03	21 : 00	Business Wire	P3 Health Partners to Present at the 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:PIII	P3 Partners Inc
2024/03/29	05 : 05	Business Wire	P3 Health Partners Announces Fourth Quarter and Full Year 2023 Results	NASDAQ:PIII	P3 Partners Inc
2024/03/15	21 : 00	Business Wire	P3 Health Partners to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024	NASDAQ:PIII	P3 Partners Inc
2024/03/07	22 : 00	Business Wire	P3 Health Partners to Present at the KeyBanc LifeSciences & Medtech Investor Forum	NASDAQ:PIII	P3 Partners Inc
2024/02/28	22 : 00	Business Wire	P3 Health Partners to Participate in the Jefferies Value Based Healthcare Summit	NASDAQ:PIII	P3 Partners Inc
2024/02/19	22 : 00	Business Wire	P3 Health Partners to Present at the TD Cowen 44th Annual Healthcare Conference	NASDAQ:PIII	P3 Partners Inc
2024/01/30	22 : 00	Business Wire	P3 Health Partners to Participate in The 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference	NASDAQ:PIII	P3 Partners Inc
2024/01/18	07 : 26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PIII	P3 Partners Inc
2024/01/18	07 : 26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PIII	P3 Partners Inc
2024/01/10	09 : 29	Business Wire	P3 Health Partners Reaffirms Guidance for 2023 and Announces Guidance for 2024	NASDAQ:PIII	P3 Partners Inc
2024/01/04	07 : 31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PIII	P3 Partners Inc
2024/01/04	07 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PIII	P3 Partners Inc
2024/01/03	07 : 30	Business Wire	P3 Health Partners to Present at the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:PIII	P3 Partners Inc
2023/11/21	20 : 02	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:PIII	P3 Partners Inc
2023/11/21	20 : 00	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:PIII	P3 Partners Inc
2023/11/21	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:PIII	P3 Partners Inc
2023/11/21	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:PIII	P3 Partners Inc
2023/11/21	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:PIII	P3 Partners Inc
2023/11/16	21 : 00	Business Wire	P3 Health Partners to Present at the BTIG Digital Health Forum	NASDAQ:PIII	P3 Partners Inc
2023/11/10	07 : 19	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:PIII	P3 Partners Inc
2023/11/10	07 : 16	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:PIII	P3 Partners Inc
2023/11/10	07 : 08	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:PIII	P3 Partners Inc
2023/11/10	06 : 13	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PIII	P3 Partners Inc
2023/11/09	07 : 03	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:PIII	P3 Partners Inc
2023/11/09	07 : 01	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:PIII	P3 Partners Inc
2023/11/09	06 : 04	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PIII	P3 Partners Inc